Valuation: Teva Pharmaceutical Industries Limited

Market Cap 40.34B 0 35.26B 32.41B 30.21B 57.29B 3,841B 58.16B 389B 151B 1,888B 151B 148B 6,505B P/E 2026 *
41.9x
P/E 2027 * 18.8x
Enterprise Value 51.52B 0 45.04B 41.39B 38.58B 73.18B 4,906B 74.29B 497B 193B 2,411B 193B 189B 8,309B EV / Sales 2026 *
3.1x
EV / Sales 2027 * 2.83x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -
1 day+1.91%
1 week+7.56%
Current month+8.57%
1 month+4.81%
3 months+13.80%
6 months+3.59%
Current year+5.85%
1 week 9,770
Extreme 9770
10,730
1 month 9,221
Extreme 9221
10,730
Current year 8,860
Extreme 8860
11,350
1 year 5,305
Extreme 5305
11,350
3 years 2,885
Extreme 2885
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
21,770
Manager TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 53 2019-12-21
Chief Operating Officer 52 2024-06-02
Director TitleAgeSince
Director/Board Member 69 2008-12-31
Chairman 78 2017-02-05
Director/Board Member 65 2015-08-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.91%+7.56% - - 40.34B
+1.86%+0.48%+55.50%+160.66% 1,082B
+3.57%+3.29%+68.60%+61.56% 633B
+3.99%+3.05%+37.93%+89.70% 461B
-1.67%+1.37%+31.00%+23.05% 338B
-1.41%-0.14%+39.73%+38.25% 299B
-0.73%+0.63%+30.11%+44.86% 291B
-0.81%+2.99%-26.50%-40.07% 222B
+3.55%+4.41%+25.45%+65.64% 202B
+4.21%+2.65%+17.47%+69.95% 163B
Average +0.42%+4.45%+31.03%+57.07% 410.27B
Weighted average by Cap. +0.04%+5.43%+41.78%+81.89%

Financials

2026 *2027 *
Net sales 16.64B 0 14.55B 13.37B 12.46B 23.64B 1,584B 23.99B 160B 62.39B 779B 62.46B 61.12B 2,684B 17.24B 0 15.07B 13.85B 12.91B 24.49B 1,642B 24.86B 166B 64.64B 807B 64.72B 63.33B 2,781B
Net income 1.54B 0 1.35B 1.24B 1.16B 2.19B 147B 2.22B 14.88B 5.78B 72.2B 5.79B 5.67B 249B 2.71B 0 2.37B 2.18B 2.03B 3.85B 258B 3.91B 26.15B 10.16B 127B 10.18B 9.96B 437B
Net Debt 11.19B 0 9.78B 8.99B 8.38B 15.89B 1,065B 16.13B 108B 41.94B 524B 41.99B 41.08B 1,804B 8.44B 0 7.38B 6.78B 6.32B 11.99B 804B 12.17B 81.4B 31.64B 395B 31.68B 31B 1,361B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
26-07-06 ILA 10,670.00 +1.81% 650,564
26-07-03 ILA 10,480.00 +0.87% 351,709
26-07-02 ILA 10,390.00 +3.08% 782,994
26-07-01 ILA 10,080.00 +2.47% 1,586,134
26-06-30 ILA 9,837.00 -0.93% 1,230,399
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
34.64USD
Average target price
40.90USD
Spread / Average Target
+18.07%

Quarterly revenue - Rate of surprise